nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—melanoma	0.291	0.541	CbGaD
Betamethasone—ABCB1—melanoma	0.247	0.46	CbGaD
Betamethasone—CYP3A4—Temozolomide—melanoma	0.0558	0.376	CbGbCtD
Betamethasone—ABCB1—Dactinomycin—melanoma	0.0339	0.229	CbGbCtD
Betamethasone—CYP3A4—Vemurafenib—melanoma	0.0306	0.206	CbGbCtD
Betamethasone—ABCB1—Docetaxel—melanoma	0.0175	0.118	CbGbCtD
Betamethasone—CYP3A4—Docetaxel—melanoma	0.0105	0.0707	CbGbCtD
Betamethasone—PLA2G1B—blood vessel—melanoma	0.00464	0.155	CbGeAlD
Betamethasone—PTGS2—leg—melanoma	0.0025	0.0833	CbGeAlD
Betamethasone—PTGS2—hindlimb—melanoma	0.00223	0.0744	CbGeAlD
Betamethasone—PGR—blood vessel—melanoma	0.00214	0.0711	CbGeAlD
Betamethasone—PTGS2—appendage—melanoma	0.00192	0.0638	CbGeAlD
Betamethasone—PTGS2—skin epidermis—melanoma	0.00159	0.0531	CbGeAlD
Betamethasone—PLA2G1B—head—melanoma	0.0014	0.0467	CbGeAlD
Betamethasone—NR3C2—retina—melanoma	0.00121	0.0404	CbGeAlD
Betamethasone—PTGS2—endothelium—melanoma	0.00116	0.0385	CbGeAlD
Betamethasone—PTGS2—blood vessel—melanoma	0.00107	0.0355	CbGeAlD
Betamethasone—NR3C2—mammalian vulva—melanoma	0.00097	0.0323	CbGeAlD
Betamethasone—NR3C1—neck—melanoma	0.000882	0.0294	CbGeAlD
Betamethasone—Skin exfoliation—Temozolomide—melanoma	0.000817	0.005	CcSEcCtD
Betamethasone—Neuropathy—Temozolomide—melanoma	0.000804	0.00492	CcSEcCtD
Betamethasone—Injury—Bleomycin—melanoma	0.000801	0.00491	CcSEcCtD
Betamethasone—Dry eye—Temozolomide—melanoma	0.000791	0.00484	CcSEcCtD
Betamethasone—Eye disorder—Vemurafenib—melanoma	0.000786	0.00481	CcSEcCtD
Betamethasone—Angiopathy—Vemurafenib—melanoma	0.000763	0.00467	CcSEcCtD
Betamethasone—Neuritis—Docetaxel—melanoma	0.000763	0.00467	CcSEcCtD
Betamethasone—Rash erythematous—Docetaxel—melanoma	0.000743	0.00455	CcSEcCtD
Betamethasone—Alopecia—Vemurafenib—melanoma	0.000743	0.00455	CcSEcCtD
Betamethasone—Thrombophlebitis—Carmustine—melanoma	0.000743	0.00455	CcSEcCtD
Betamethasone—Diabetes mellitus—Carmustine—melanoma	0.000739	0.00452	CcSEcCtD
Betamethasone—Erythema—Vemurafenib—melanoma	0.000732	0.00448	CcSEcCtD
Betamethasone—Necrosis—Docetaxel—melanoma	0.000725	0.00444	CcSEcCtD
Betamethasone—Thrombophlebitis—Temozolomide—melanoma	0.000718	0.00439	CcSEcCtD
Betamethasone—Eye pain—Carmustine—melanoma	0.000712	0.00436	CcSEcCtD
Betamethasone—Lethargy—Dactinomycin—melanoma	0.000701	0.00429	CcSEcCtD
Betamethasone—Injury—Carmustine—melanoma	0.0007	0.00428	CcSEcCtD
Betamethasone—NR3C2—head—melanoma	0.000694	0.0231	CbGeAlD
Betamethasone—Eye pain—Temozolomide—melanoma	0.000688	0.00421	CcSEcCtD
Betamethasone—ABCB1—blood vessel—melanoma	0.00066	0.022	CbGeAlD
Betamethasone—NR3C1—eye—melanoma	0.000656	0.0218	CbGeAlD
Betamethasone—Extravasation—Docetaxel—melanoma	0.000652	0.00399	CcSEcCtD
Betamethasone—Amenorrhoea—Docetaxel—melanoma	0.000648	0.00397	CcSEcCtD
Betamethasone—PGR—head—melanoma	0.000645	0.0215	CbGeAlD
Betamethasone—Myalgia—Vemurafenib—melanoma	0.000623	0.00382	CcSEcCtD
Betamethasone—Affect lability—Temozolomide—melanoma	0.000612	0.00374	CcSEcCtD
Betamethasone—Anaphylactic shock—Vemurafenib—melanoma	0.000598	0.00366	CcSEcCtD
Betamethasone—Infection—Vemurafenib—melanoma	0.000594	0.00363	CcSEcCtD
Betamethasone—Mood swings—Temozolomide—melanoma	0.000589	0.0036	CcSEcCtD
Betamethasone—Nervous system disorder—Vemurafenib—melanoma	0.000586	0.00359	CcSEcCtD
Betamethasone—Hypokalaemia—Carmustine—melanoma	0.000585	0.00358	CcSEcCtD
Betamethasone—CYP19A1—head—melanoma	0.000581	0.0193	CbGeAlD
Betamethasone—Weight decreased—Bleomycin—melanoma	0.000576	0.00353	CcSEcCtD
Betamethasone—NR3C1—skin of body—melanoma	0.000571	0.019	CbGeAlD
Betamethasone—Dry skin—Temozolomide—melanoma	0.00057	0.00349	CcSEcCtD
Betamethasone—Muscular weakness—Carmustine—melanoma	0.000567	0.00347	CcSEcCtD
Betamethasone—Hypokalaemia—Temozolomide—melanoma	0.000566	0.00346	CcSEcCtD
Betamethasone—Acute coronary syndrome—Bleomycin—melanoma	0.00056	0.00343	CcSEcCtD
Betamethasone—Hypotension—Vemurafenib—melanoma	0.000558	0.00342	CcSEcCtD
Betamethasone—Myocardial infarction—Bleomycin—melanoma	0.000556	0.00341	CcSEcCtD
Betamethasone—Muscular weakness—Temozolomide—melanoma	0.000548	0.00335	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000544	0.00333	CcSEcCtD
Betamethasone—Skin exfoliation—Docetaxel—melanoma	0.000544	0.00333	CcSEcCtD
Betamethasone—Fluid retention—Docetaxel—melanoma	0.00054	0.00331	CcSEcCtD
Betamethasone—Neuropathy—Docetaxel—melanoma	0.000535	0.00327	CcSEcCtD
Betamethasone—Sweating increased—Temozolomide—melanoma	0.000523	0.0032	CcSEcCtD
Betamethasone—NR3C1—mammalian vulva—melanoma	0.00052	0.0173	CbGeAlD
Betamethasone—Oesophagitis—Docetaxel—melanoma	0.00052	0.00318	CcSEcCtD
Betamethasone—Decreased appetite—Vemurafenib—melanoma	0.00052	0.00318	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Vemurafenib—melanoma	0.000516	0.00316	CcSEcCtD
Betamethasone—Fatigue—Vemurafenib—melanoma	0.000515	0.00315	CcSEcCtD
Betamethasone—Haemoglobin—Bleomycin—melanoma	0.000512	0.00314	CcSEcCtD
Betamethasone—Haemorrhage—Bleomycin—melanoma	0.00051	0.00312	CcSEcCtD
Betamethasone—Pulmonary oedema—Docetaxel—melanoma	0.000507	0.0031	CcSEcCtD
Betamethasone—Hyperglycaemia—Carmustine—melanoma	0.000501	0.00307	CcSEcCtD
Betamethasone—PTGS2—skin of body—melanoma	0.000494	0.0165	CbGeAlD
Betamethasone—Weight increased—Temozolomide—melanoma	0.000489	0.00299	CcSEcCtD
Betamethasone—NR3C2—lymph node—melanoma	0.000486	0.0162	CbGeAlD
Betamethasone—Weight decreased—Temozolomide—melanoma	0.000486	0.00297	CcSEcCtD
Betamethasone—Neuropathy peripheral—Carmustine—melanoma	0.000486	0.00297	CcSEcCtD
Betamethasone—Hyperglycaemia—Temozolomide—melanoma	0.000484	0.00297	CcSEcCtD
Betamethasone—Thrombophlebitis—Docetaxel—melanoma	0.000477	0.00292	CcSEcCtD
Betamethasone—Body temperature increased—Vemurafenib—melanoma	0.000472	0.00289	CcSEcCtD
Betamethasone—Neuropathy peripheral—Temozolomide—melanoma	0.000469	0.00287	CcSEcCtD
Betamethasone—Cardiac failure congestive—Docetaxel—melanoma	0.000456	0.00279	CcSEcCtD
Betamethasone—PGR—lymph node—melanoma	0.000452	0.015	CbGeAlD
Betamethasone—Alopecia—Bleomycin—melanoma	0.00045	0.00276	CcSEcCtD
Betamethasone—Haemoglobin—Carmustine—melanoma	0.000447	0.00274	CcSEcCtD
Betamethasone—Haemorrhage—Carmustine—melanoma	0.000445	0.00272	CcSEcCtD
Betamethasone—Erythema—Bleomycin—melanoma	0.000444	0.00272	CcSEcCtD
Betamethasone—Hallucination—Carmustine—melanoma	0.000443	0.00271	CcSEcCtD
Betamethasone—Visual disturbance—Docetaxel—melanoma	0.000436	0.00267	CcSEcCtD
Betamethasone—Dermatitis bullous—Docetaxel—melanoma	0.000432	0.00265	CcSEcCtD
Betamethasone—Haemoglobin—Temozolomide—melanoma	0.000432	0.00264	CcSEcCtD
Betamethasone—Haemorrhage—Temozolomide—melanoma	0.00043	0.00263	CcSEcCtD
Betamethasone—Asthenia—Vemurafenib—melanoma	0.000429	0.00262	CcSEcCtD
Betamethasone—Visual impairment—Carmustine—melanoma	0.000429	0.00262	CcSEcCtD
Betamethasone—Hallucination—Temozolomide—melanoma	0.000428	0.00262	CcSEcCtD
Betamethasone—Cardiac failure—Docetaxel—melanoma	0.000423	0.00259	CcSEcCtD
Betamethasone—Pruritus—Vemurafenib—melanoma	0.000423	0.00259	CcSEcCtD
Betamethasone—Lethargy—Docetaxel—melanoma	0.000422	0.00258	CcSEcCtD
Betamethasone—Alopecia—Dactinomycin—melanoma	0.00042	0.00257	CcSEcCtD
Betamethasone—Eye disorder—Carmustine—melanoma	0.000416	0.00254	CcSEcCtD
Betamethasone—Visual impairment—Temozolomide—melanoma	0.000414	0.00254	CcSEcCtD
Betamethasone—Erythema—Dactinomycin—melanoma	0.000414	0.00253	CcSEcCtD
Betamethasone—Ill-defined disorder—Bleomycin—melanoma	0.000412	0.00252	CcSEcCtD
Betamethasone—Diarrhoea—Vemurafenib—melanoma	0.000409	0.0025	CcSEcCtD
Betamethasone—Migraine—Docetaxel—melanoma	0.000407	0.00249	CcSEcCtD
Betamethasone—CYP19A1—lymph node—melanoma	0.000407	0.0135	CbGeAlD
Betamethasone—Eye disorder—Temozolomide—melanoma	0.000402	0.00246	CcSEcCtD
Betamethasone—Malaise—Bleomycin—melanoma	0.0004	0.00245	CcSEcCtD
Betamethasone—Arrhythmia—Carmustine—melanoma	0.000397	0.00243	CcSEcCtD
Betamethasone—Dizziness—Vemurafenib—melanoma	0.000395	0.00242	CcSEcCtD
Betamethasone—Alopecia—Carmustine—melanoma	0.000393	0.00241	CcSEcCtD
Betamethasone—Angiopathy—Temozolomide—melanoma	0.00039	0.00239	CcSEcCtD
Betamethasone—Erythema—Carmustine—melanoma	0.000387	0.00237	CcSEcCtD
Betamethasone—Ill-defined disorder—Dactinomycin—melanoma	0.000384	0.00235	CcSEcCtD
Betamethasone—Vomiting—Vemurafenib—melanoma	0.00038	0.00233	CcSEcCtD
Betamethasone—Alopecia—Temozolomide—melanoma	0.00038	0.00233	CcSEcCtD
Betamethasone—Dry skin—Docetaxel—melanoma	0.000379	0.00232	CcSEcCtD
Betamethasone—Myalgia—Bleomycin—melanoma	0.000378	0.00231	CcSEcCtD
Betamethasone—Rash—Vemurafenib—melanoma	0.000377	0.00231	CcSEcCtD
Betamethasone—Dermatitis—Vemurafenib—melanoma	0.000376	0.0023	CcSEcCtD
Betamethasone—Headache—Vemurafenib—melanoma	0.000374	0.00229	CcSEcCtD
Betamethasone—Erythema—Temozolomide—melanoma	0.000374	0.00229	CcSEcCtD
Betamethasone—Discomfort—Bleomycin—melanoma	0.000373	0.00228	CcSEcCtD
Betamethasone—Malaise—Dactinomycin—melanoma	0.000373	0.00228	CcSEcCtD
Betamethasone—NR3C1—head—melanoma	0.000372	0.0124	CbGeAlD
Betamethasone—Oedema—Bleomycin—melanoma	0.000362	0.00222	CcSEcCtD
Betamethasone—Anaphylactic shock—Bleomycin—melanoma	0.000362	0.00222	CcSEcCtD
Betamethasone—Infection—Bleomycin—melanoma	0.00036	0.0022	CcSEcCtD
Betamethasone—Nausea—Vemurafenib—melanoma	0.000355	0.00217	CcSEcCtD
Betamethasone—Thrombocytopenia—Bleomycin—melanoma	0.000355	0.00217	CcSEcCtD
Betamethasone—Myalgia—Dactinomycin—melanoma	0.000352	0.00216	CcSEcCtD
Betamethasone—Discomfort—Dactinomycin—melanoma	0.000348	0.00213	CcSEcCtD
Betamethasone—ABCB1—retina—melanoma	0.000348	0.0116	CbGeAlD
Betamethasone—Ill-defined disorder—Temozolomide—melanoma	0.000347	0.00213	CcSEcCtD
Betamethasone—Anorexia—Bleomycin—melanoma	0.000345	0.00211	CcSEcCtD
Betamethasone—Angioedema—Temozolomide—melanoma	0.000342	0.00209	CcSEcCtD
Betamethasone—Hypotension—Bleomycin—melanoma	0.000338	0.00207	CcSEcCtD
Betamethasone—Oedema—Dactinomycin—melanoma	0.000338	0.00207	CcSEcCtD
Betamethasone—Malaise—Temozolomide—melanoma	0.000337	0.00207	CcSEcCtD
Betamethasone—Vertigo—Temozolomide—melanoma	0.000336	0.00206	CcSEcCtD
Betamethasone—Convulsion—Carmustine—melanoma	0.000336	0.00205	CcSEcCtD
Betamethasone—Infection—Dactinomycin—melanoma	0.000335	0.00205	CcSEcCtD
Betamethasone—Hypertension—Carmustine—melanoma	0.000334	0.00205	CcSEcCtD
Betamethasone—Thrombocytopenia—Dactinomycin—melanoma	0.000331	0.00202	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00033	0.00202	CcSEcCtD
Betamethasone—Myalgia—Carmustine—melanoma	0.00033	0.00202	CcSEcCtD
Betamethasone—Anxiety—Carmustine—melanoma	0.000329	0.00201	CcSEcCtD
Betamethasone—Paraesthesia—Bleomycin—melanoma	0.000325	0.00199	CcSEcCtD
Betamethasone—Weight increased—Docetaxel—melanoma	0.000325	0.00199	CcSEcCtD
Betamethasone—Convulsion—Temozolomide—melanoma	0.000324	0.00198	CcSEcCtD
Betamethasone—Weight decreased—Docetaxel—melanoma	0.000323	0.00198	CcSEcCtD
Betamethasone—Hypertension—Temozolomide—melanoma	0.000323	0.00198	CcSEcCtD
Betamethasone—PTGS2—head—melanoma	0.000322	0.0107	CbGeAlD
Betamethasone—Anorexia—Dactinomycin—melanoma	0.000322	0.00197	CcSEcCtD
Betamethasone—Myalgia—Temozolomide—melanoma	0.000319	0.00195	CcSEcCtD
Betamethasone—Anxiety—Temozolomide—melanoma	0.000318	0.00194	CcSEcCtD
Betamethasone—Oedema—Carmustine—melanoma	0.000316	0.00193	CcSEcCtD
Betamethasone—Discomfort—Temozolomide—melanoma	0.000315	0.00193	CcSEcCtD
Betamethasone—Decreased appetite—Bleomycin—melanoma	0.000315	0.00193	CcSEcCtD
Betamethasone—Infection—Carmustine—melanoma	0.000314	0.00192	CcSEcCtD
Betamethasone—Acute coronary syndrome—Docetaxel—melanoma	0.000314	0.00192	CcSEcCtD
Betamethasone—Myocardial infarction—Docetaxel—melanoma	0.000312	0.00191	CcSEcCtD
Betamethasone—Neuropathy peripheral—Docetaxel—melanoma	0.000312	0.00191	CcSEcCtD
Betamethasone—Pain—Bleomycin—melanoma	0.00031	0.0019	CcSEcCtD
Betamethasone—Conjunctivitis—Docetaxel—melanoma	0.00031	0.00189	CcSEcCtD
Betamethasone—Thrombocytopenia—Carmustine—melanoma	0.000309	0.00189	CcSEcCtD
Betamethasone—Tachycardia—Carmustine—melanoma	0.000308	0.00189	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000308	0.00188	CcSEcCtD
Betamethasone—Anaphylactic shock—Temozolomide—melanoma	0.000305	0.00187	CcSEcCtD
Betamethasone—Oedema—Temozolomide—melanoma	0.000305	0.00187	CcSEcCtD
Betamethasone—Infection—Temozolomide—melanoma	0.000303	0.00186	CcSEcCtD
Betamethasone—Anorexia—Carmustine—melanoma	0.000301	0.00184	CcSEcCtD
Betamethasone—Nervous system disorder—Temozolomide—melanoma	0.0003	0.00183	CcSEcCtD
Betamethasone—Thrombocytopenia—Temozolomide—melanoma	0.000299	0.00183	CcSEcCtD
Betamethasone—Feeling abnormal—Bleomycin—melanoma	0.000298	0.00183	CcSEcCtD
Betamethasone—Hypotension—Carmustine—melanoma	0.000295	0.00181	CcSEcCtD
Betamethasone—Hyperhidrosis—Temozolomide—melanoma	0.000295	0.00181	CcSEcCtD
Betamethasone—Decreased appetite—Dactinomycin—melanoma	0.000294	0.0018	CcSEcCtD
Betamethasone—Fatigue—Dactinomycin—melanoma	0.000291	0.00178	CcSEcCtD
Betamethasone—Anorexia—Temozolomide—melanoma	0.000291	0.00178	CcSEcCtD
Betamethasone—Pain—Dactinomycin—melanoma	0.000289	0.00177	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Carmustine—melanoma	0.000288	0.00176	CcSEcCtD
Betamethasone—Urticaria—Bleomycin—melanoma	0.000288	0.00176	CcSEcCtD
Betamethasone—Haemoglobin—Docetaxel—melanoma	0.000287	0.00176	CcSEcCtD
Betamethasone—Body temperature increased—Bleomycin—melanoma	0.000286	0.00175	CcSEcCtD
Betamethasone—Haemorrhage—Docetaxel—melanoma	0.000286	0.00175	CcSEcCtD
Betamethasone—Insomnia—Carmustine—melanoma	0.000286	0.00175	CcSEcCtD
Betamethasone—Paraesthesia—Carmustine—melanoma	0.000284	0.00174	CcSEcCtD
Betamethasone—ABCB1—mammalian vulva—melanoma	0.000279	0.00928	CbGeAlD
Betamethasone—Feeling abnormal—Dactinomycin—melanoma	0.000278	0.0017	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000278	0.0017	CcSEcCtD
Betamethasone—Insomnia—Temozolomide—melanoma	0.000276	0.00169	CcSEcCtD
Betamethasone—Gastrointestinal pain—Dactinomycin—melanoma	0.000276	0.00169	CcSEcCtD
Betamethasone—Visual impairment—Docetaxel—melanoma	0.000276	0.00169	CcSEcCtD
Betamethasone—Decreased appetite—Carmustine—melanoma	0.000275	0.00168	CcSEcCtD
Betamethasone—Paraesthesia—Temozolomide—melanoma	0.000274	0.00168	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Carmustine—melanoma	0.000273	0.00167	CcSEcCtD
Betamethasone—Pain—Carmustine—melanoma	0.00027	0.00165	CcSEcCtD
Betamethasone—Dyspepsia—Temozolomide—melanoma	0.000269	0.00165	CcSEcCtD
Betamethasone—Dexamethasone—CYP17A1—melanoma	0.000267	0.168	CrCbGaD
Betamethasone—Eye disorder—Docetaxel—melanoma	0.000267	0.00164	CcSEcCtD
Betamethasone—Body temperature increased—Dactinomycin—melanoma	0.000267	0.00163	CcSEcCtD
Betamethasone—Abdominal pain—Dactinomycin—melanoma	0.000267	0.00163	CcSEcCtD
Betamethasone—Decreased appetite—Temozolomide—melanoma	0.000266	0.00163	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Temozolomide—melanoma	0.000264	0.00161	CcSEcCtD
Betamethasone—Fatigue—Temozolomide—melanoma	0.000263	0.00161	CcSEcCtD
Betamethasone—Pain—Temozolomide—melanoma	0.000261	0.0016	CcSEcCtD
Betamethasone—NR3C1—lymph node—melanoma	0.000261	0.00868	CbGeAlD
Betamethasone—Feeling abnormal—Carmustine—melanoma	0.00026	0.00159	CcSEcCtD
Betamethasone—Asthenia—Bleomycin—melanoma	0.00026	0.00159	CcSEcCtD
Betamethasone—Angiopathy—Docetaxel—melanoma	0.000259	0.00159	CcSEcCtD
Betamethasone—Gastrointestinal pain—Carmustine—melanoma	0.000258	0.00158	CcSEcCtD
Betamethasone—Pruritus—Bleomycin—melanoma	0.000256	0.00157	CcSEcCtD
Betamethasone—Arrhythmia—Docetaxel—melanoma	0.000255	0.00156	CcSEcCtD
Betamethasone—Alopecia—Docetaxel—melanoma	0.000253	0.00155	CcSEcCtD
Betamethasone—Feeling abnormal—Temozolomide—melanoma	0.000252	0.00154	CcSEcCtD
Betamethasone—Abdominal pain—Carmustine—melanoma	0.00025	0.00153	CcSEcCtD
Betamethasone—Body temperature increased—Carmustine—melanoma	0.00025	0.00153	CcSEcCtD
Betamethasone—Gastrointestinal pain—Temozolomide—melanoma	0.00025	0.00153	CcSEcCtD
Betamethasone—Erythema—Docetaxel—melanoma	0.000249	0.00152	CcSEcCtD
Betamethasone—Urticaria—Temozolomide—melanoma	0.000243	0.00149	CcSEcCtD
Betamethasone—Asthenia—Dactinomycin—melanoma	0.000242	0.00148	CcSEcCtD
Betamethasone—Abdominal pain—Temozolomide—melanoma	0.000241	0.00148	CcSEcCtD
Betamethasone—Body temperature increased—Temozolomide—melanoma	0.000241	0.00148	CcSEcCtD
Betamethasone—Diarrhoea—Dactinomycin—melanoma	0.000231	0.00141	CcSEcCtD
Betamethasone—Vomiting—Bleomycin—melanoma	0.00023	0.00141	CcSEcCtD
Betamethasone—Rash—Bleomycin—melanoma	0.000228	0.0014	CcSEcCtD
Betamethasone—Dermatitis—Bleomycin—melanoma	0.000228	0.0014	CcSEcCtD
Betamethasone—Asthenia—Carmustine—melanoma	0.000227	0.00139	CcSEcCtD
Betamethasone—PTGS2—lymph node—melanoma	0.000226	0.00752	CbGeAlD
Betamethasone—Syncope—Docetaxel—melanoma	0.000223	0.00137	CcSEcCtD
Betamethasone—Asthenia—Temozolomide—melanoma	0.000219	0.00134	CcSEcCtD
Betamethasone—Loss of consciousness—Docetaxel—melanoma	0.000219	0.00134	CcSEcCtD
Betamethasone—Dexamethasone—NOS2—melanoma	0.000218	0.137	CrCbGaD
Betamethasone—Diarrhoea—Carmustine—melanoma	0.000216	0.00132	CcSEcCtD
Betamethasone—Pruritus—Temozolomide—melanoma	0.000216	0.00132	CcSEcCtD
Betamethasone—Convulsion—Docetaxel—melanoma	0.000216	0.00132	CcSEcCtD
Betamethasone—Nausea—Bleomycin—melanoma	0.000215	0.00132	CcSEcCtD
Betamethasone—Hypertension—Docetaxel—melanoma	0.000215	0.00132	CcSEcCtD
Betamethasone—Vomiting—Dactinomycin—melanoma	0.000215	0.00131	CcSEcCtD
Betamethasone—Rash—Dactinomycin—melanoma	0.000213	0.0013	CcSEcCtD
Betamethasone—Myalgia—Docetaxel—melanoma	0.000212	0.0013	CcSEcCtD
Betamethasone—Dizziness—Carmustine—melanoma	0.000209	0.00128	CcSEcCtD
Betamethasone—Diarrhoea—Temozolomide—melanoma	0.000209	0.00128	CcSEcCtD
Betamethasone—Anaphylactic shock—Docetaxel—melanoma	0.000203	0.00124	CcSEcCtD
Betamethasone—Oedema—Docetaxel—melanoma	0.000203	0.00124	CcSEcCtD
Betamethasone—Dizziness—Temozolomide—melanoma	0.000202	0.00124	CcSEcCtD
Betamethasone—Infection—Docetaxel—melanoma	0.000202	0.00124	CcSEcCtD
Betamethasone—Vomiting—Carmustine—melanoma	0.000201	0.00123	CcSEcCtD
Betamethasone—Nausea—Dactinomycin—melanoma	0.000201	0.00123	CcSEcCtD
Betamethasone—Shock—Docetaxel—melanoma	0.0002	0.00122	CcSEcCtD
Betamethasone—ABCB1—head—melanoma	0.000199	0.00664	CbGeAlD
Betamethasone—Rash—Carmustine—melanoma	0.000199	0.00122	CcSEcCtD
Betamethasone—Nervous system disorder—Docetaxel—melanoma	0.000199	0.00122	CcSEcCtD
Betamethasone—Dermatitis—Carmustine—melanoma	0.000199	0.00122	CcSEcCtD
Betamethasone—Thrombocytopenia—Docetaxel—melanoma	0.000199	0.00122	CcSEcCtD
Betamethasone—Tachycardia—Docetaxel—melanoma	0.000198	0.00121	CcSEcCtD
Betamethasone—Headache—Carmustine—melanoma	0.000198	0.00121	CcSEcCtD
Betamethasone—Vomiting—Temozolomide—melanoma	0.000194	0.00119	CcSEcCtD
Betamethasone—Anorexia—Docetaxel—melanoma	0.000194	0.00118	CcSEcCtD
Betamethasone—Rash—Temozolomide—melanoma	0.000193	0.00118	CcSEcCtD
Betamethasone—Dermatitis—Temozolomide—melanoma	0.000192	0.00118	CcSEcCtD
Betamethasone—Headache—Temozolomide—melanoma	0.000191	0.00117	CcSEcCtD
Betamethasone—Hypotension—Docetaxel—melanoma	0.00019	0.00116	CcSEcCtD
Betamethasone—Nausea—Carmustine—melanoma	0.000188	0.00115	CcSEcCtD
Betamethasone—Dexamethasone—CYP1B1—melanoma	0.000185	0.117	CrCbGaD
Betamethasone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000185	0.00113	CcSEcCtD
Betamethasone—Insomnia—Docetaxel—melanoma	0.000184	0.00112	CcSEcCtD
Betamethasone—Paraesthesia—Docetaxel—melanoma	0.000182	0.00112	CcSEcCtD
Betamethasone—Nausea—Temozolomide—melanoma	0.000181	0.00111	CcSEcCtD
Betamethasone—Dyspepsia—Docetaxel—melanoma	0.000179	0.00109	CcSEcCtD
Betamethasone—Decreased appetite—Docetaxel—melanoma	0.000177	0.00108	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Docetaxel—melanoma	0.000175	0.00107	CcSEcCtD
Betamethasone—Fatigue—Docetaxel—melanoma	0.000175	0.00107	CcSEcCtD
Betamethasone—Pain—Docetaxel—melanoma	0.000174	0.00106	CcSEcCtD
Betamethasone—Feeling abnormal—Docetaxel—melanoma	0.000167	0.00102	CcSEcCtD
Betamethasone—Gastrointestinal pain—Docetaxel—melanoma	0.000166	0.00102	CcSEcCtD
Betamethasone—Fluticasone furoate—ABCB1—melanoma	0.000166	0.105	CrCbGaD
Betamethasone—Abdominal pain—Docetaxel—melanoma	0.000161	0.000983	CcSEcCtD
Betamethasone—Body temperature increased—Docetaxel—melanoma	0.000161	0.000983	CcSEcCtD
Betamethasone—Asthenia—Docetaxel—melanoma	0.000146	0.000892	CcSEcCtD
Betamethasone—Pruritus—Docetaxel—melanoma	0.000144	0.00088	CcSEcCtD
Betamethasone—ABCB1—lymph node—melanoma	0.00014	0.00465	CbGeAlD
Betamethasone—Diarrhoea—Docetaxel—melanoma	0.000139	0.000851	CcSEcCtD
Betamethasone—Dizziness—Docetaxel—melanoma	0.000134	0.000822	CcSEcCtD
Betamethasone—Methylprednisolone—ABCB1—melanoma	0.000132	0.0833	CrCbGaD
Betamethasone—Triamcinolone—PTGS2—melanoma	0.000131	0.0826	CrCbGaD
Betamethasone—Vomiting—Docetaxel—melanoma	0.000129	0.00079	CcSEcCtD
Betamethasone—Rash—Docetaxel—melanoma	0.000128	0.000784	CcSEcCtD
Betamethasone—Dermatitis—Docetaxel—melanoma	0.000128	0.000783	CcSEcCtD
Betamethasone—Headache—Docetaxel—melanoma	0.000127	0.000779	CcSEcCtD
Betamethasone—Nausea—Docetaxel—melanoma	0.000121	0.000738	CcSEcCtD
Betamethasone—Prednisone—ALB—melanoma	0.000106	0.0668	CrCbGaD
Betamethasone—Prednisone—ABCB1—melanoma	0.000101	0.0637	CrCbGaD
Betamethasone—Prednisolone—ABCB1—melanoma	9.33e-05	0.0587	CrCbGaD
Betamethasone—Hydrocortisone—ABCB1—melanoma	7.13e-05	0.0449	CrCbGaD
Betamethasone—Dexamethasone—PTGS2—melanoma	6.25e-05	0.0394	CrCbGaD
Betamethasone—Dexamethasone—ABCB1—melanoma	5.32e-05	0.0335	CrCbGaD
Betamethasone—NR3C2—Gene Expression—MAPK3—melanoma	2.5e-05	0.000211	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC5A5—melanoma	2.5e-05	0.000211	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTEN—melanoma	2.49e-05	0.00021	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN2B—melanoma	2.49e-05	0.00021	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.46e-05	0.000208	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—melanoma	2.43e-05	0.000205	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PLA2G6—melanoma	2.42e-05	0.000204	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GNAQ—melanoma	2.41e-05	0.000203	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CD44—melanoma	2.41e-05	0.000203	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—UGT2B10—melanoma	2.41e-05	0.000203	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CD86—melanoma	2.4e-05	0.000203	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.4e-05	0.000202	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EDN1—melanoma	2.38e-05	0.000201	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.37e-05	0.0002	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.36e-05	0.000199	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.34e-05	0.000197	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGF1—melanoma	2.33e-05	0.000197	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CSF2—melanoma	2.33e-05	0.000197	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.32e-05	0.000196	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.31e-05	0.000195	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP1B1—melanoma	2.31e-05	0.000195	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.3e-05	0.000194	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.3e-05	0.000194	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—E2F1—melanoma	2.28e-05	0.000192	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PDGFRA—melanoma	2.26e-05	0.00019	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PHGDH—melanoma	2.24e-05	0.000189	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LUM—melanoma	2.24e-05	0.000189	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HS3ST5—melanoma	2.24e-05	0.000189	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PRKCA—melanoma	2.23e-05	0.000188	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ITGB3—melanoma	2.23e-05	0.000188	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.23e-05	0.000188	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CDKN2B—melanoma	2.21e-05	0.000186	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HPSE—melanoma	2.2e-05	0.000185	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SPP1—melanoma	2.19e-05	0.000185	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAP2K2—melanoma	2.18e-05	0.000184	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—VCAN—melanoma	2.18e-05	0.000183	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CUBN—melanoma	2.16e-05	0.000182	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—VDR—melanoma	2.15e-05	0.000182	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	2.09e-05	0.000176	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SDHD—melanoma	2.08e-05	0.000176	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CSPG4—melanoma	2.08e-05	0.000176	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BSG—melanoma	2.08e-05	0.000176	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TERT—melanoma	2.08e-05	0.000175	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RAC1—melanoma	2.07e-05	0.000175	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GAB2—melanoma	2.07e-05	0.000174	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.06e-05	0.000174	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.04e-05	0.000172	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FASN—melanoma	2.03e-05	0.000171	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GPAM—melanoma	2.02e-05	0.00017	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.99e-05	0.000168	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HIF1A—melanoma	1.99e-05	0.000168	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PRKCA—melanoma	1.99e-05	0.000168	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.98e-05	0.000167	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ERCC2—melanoma	1.97e-05	0.000166	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CXCR4—melanoma	1.95e-05	0.000164	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FOXO4—melanoma	1.95e-05	0.000164	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HDAC2—melanoma	1.95e-05	0.000164	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD44—melanoma	1.92e-05	0.000162	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.92e-05	0.000162	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ABCB1—melanoma	1.9e-05	0.000161	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KDR—melanoma	1.9e-05	0.00016	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.88e-05	0.000159	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.88e-05	0.000159	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.88e-05	0.000159	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP17A1—melanoma	1.84e-05	0.000155	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FN1—melanoma	1.83e-05	0.000154	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.81e-05	0.000153	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.79e-05	0.000151	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH1—melanoma	1.79e-05	0.000151	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.79e-05	0.000151	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—melanoma	1.78e-05	0.00015	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.78e-05	0.00015	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT3—melanoma	1.78e-05	0.00015	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—melanoma	1.76e-05	0.000148	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CD80—melanoma	1.75e-05	0.000148	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PRKCA—melanoma	1.75e-05	0.000148	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APC—melanoma	1.75e-05	0.000148	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KIT—melanoma	1.75e-05	0.000148	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CG—melanoma	1.75e-05	0.000148	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ERCC2—melanoma	1.74e-05	0.000147	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GNA11—melanoma	1.73e-05	0.000146	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGF—melanoma	1.73e-05	0.000146	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PLA2G6—melanoma	1.72e-05	0.000145	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—FASN—melanoma	1.7e-05	0.000143	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLCB4—melanoma	1.69e-05	0.000143	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—melanoma	1.69e-05	0.000142	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC5A5—melanoma	1.67e-05	0.000141	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BRAF—melanoma	1.65e-05	0.000139	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.63e-05	0.000138	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GNAQ—melanoma	1.61e-05	0.000136	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CD44—melanoma	1.61e-05	0.000136	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1—melanoma	1.6e-05	0.000135	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC6A11—melanoma	1.59e-05	0.000134	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIP4K2A—melanoma	1.59e-05	0.000134	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH1—melanoma	1.59e-05	0.000134	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.58e-05	0.000133	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.58e-05	0.000133	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB4—melanoma	1.57e-05	0.000132	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN2B—melanoma	1.55e-05	0.000131	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTAP—melanoma	1.55e-05	0.000131	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAP2K1—melanoma	1.55e-05	0.000131	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1B1—melanoma	1.54e-05	0.00013	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—VCAN—melanoma	1.54e-05	0.00013	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CD—melanoma	1.54e-05	0.00013	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MAPK3—melanoma	1.52e-05	0.000128	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD86—melanoma	1.5e-05	0.000127	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARG—melanoma	1.5e-05	0.000127	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—melanoma	1.48e-05	0.000125	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGF2—melanoma	1.47e-05	0.000124	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGF1—melanoma	1.46e-05	0.000123	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.44e-05	0.000121	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—melanoma	1.43e-05	0.000121	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PDGFRA—melanoma	1.41e-05	0.000119	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PRKCA—melanoma	1.4e-05	0.000118	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERCC2—melanoma	1.39e-05	0.000117	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LUM—melanoma	1.38e-05	0.000116	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PHGDH—melanoma	1.38e-05	0.000116	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MDM2—melanoma	1.38e-05	0.000116	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CG—melanoma	1.37e-05	0.000116	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAP2K2—melanoma	1.37e-05	0.000115	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.36e-05	0.000115	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB2—melanoma	1.36e-05	0.000115	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HPSE—melanoma	1.35e-05	0.000114	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CB—melanoma	1.34e-05	0.000113	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.33e-05	0.000112	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CUBN—melanoma	1.33e-05	0.000112	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARG—melanoma	1.32e-05	0.000112	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP17A1—melanoma	1.3e-05	0.00011	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HLA-A—melanoma	1.3e-05	0.00011	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TERT—melanoma	1.3e-05	0.00011	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RAC1—melanoma	1.3e-05	0.000109	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—melanoma	1.29e-05	0.000109	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SDHD—melanoma	1.28e-05	0.000108	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CSPG4—melanoma	1.28e-05	0.000108	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BSG—melanoma	1.28e-05	0.000108	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCB1—melanoma	1.27e-05	0.000107	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1B—melanoma	1.26e-05	0.000106	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GPAM—melanoma	1.24e-05	0.000105	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HIF1A—melanoma	1.24e-05	0.000105	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—melanoma	1.23e-05	0.000104	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—melanoma	1.23e-05	0.000104	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNA11—melanoma	1.23e-05	0.000104	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CD—melanoma	1.21e-05	0.000102	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.2e-05	0.000102	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—FASN—melanoma	1.2e-05	0.000101	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—melanoma	1.2e-05	0.000101	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ALB—melanoma	1.19e-05	0.0001	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CTNNB1—melanoma	1.19e-05	0.0001	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC5A5—melanoma	1.18e-05	9.97e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PRKCA—melanoma	1.17e-05	9.87e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—melanoma	1.17e-05	9.83e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1A—melanoma	1.16e-05	9.79e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ERCC2—melanoma	1.16e-05	9.79e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—melanoma	1.16e-05	9.77e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NFKB1—melanoma	1.15e-05	9.73e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNAQ—melanoma	1.14e-05	9.63e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CD44—melanoma	1.14e-05	9.63e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS2—melanoma	1.13e-05	9.53e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOTCH1—melanoma	1.12e-05	9.44e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD80—melanoma	1.1e-05	9.25e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1B1—melanoma	1.1e-05	9.23e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KIT—melanoma	1.09e-05	9.23e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APC—melanoma	1.09e-05	9.23e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGF—melanoma	1.08e-05	9.13e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLA2G6—melanoma	1.06e-05	8.92e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CB—melanoma	1.05e-05	8.87e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—melanoma	1.05e-05	8.83e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—melanoma	1.04e-05	8.79e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—melanoma	1.04e-05	8.74e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRAS—melanoma	1.03e-05	8.72e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BRAF—melanoma	1.03e-05	8.68e-05	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—melanoma	1.03e-05	8.66e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK3—melanoma	9.9e-06	8.35e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAP2K1—melanoma	9.69e-06	8.17e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—melanoma	9.63e-06	8.12e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CD—melanoma	9.63e-06	8.12e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.62e-06	8.11e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—VCAN—melanoma	9.5e-06	8.01e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK1—melanoma	9.42e-06	7.94e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—melanoma	9.42e-06	7.94e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGF2—melanoma	9.22e-06	7.77e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CG—melanoma	9.17e-06	7.73e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—melanoma	9.09e-06	7.66e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—melanoma	8.9e-06	7.5e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARG—melanoma	8.85e-06	7.46e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAPK3—melanoma	8.8e-06	7.42e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MDM2—melanoma	8.62e-06	7.27e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—melanoma	8.56e-06	7.22e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB2—melanoma	8.5e-06	7.17e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CB—melanoma	8.39e-06	7.07e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD4—melanoma	8.37e-06	7.06e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PRKCA—melanoma	8.3e-06	7e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ERCC2—melanoma	8.23e-06	6.94e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—melanoma	8.18e-06	6.89e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CD—melanoma	8.06e-06	6.8e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP17A1—melanoma	8.02e-06	6.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALB—melanoma	7.96e-06	6.71e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—melanoma	7.91e-06	6.67e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1B—melanoma	7.87e-06	6.64e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNA11—melanoma	7.57e-06	6.38e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—melanoma	7.56e-06	6.38e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CTNNB1—melanoma	7.44e-06	6.27e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—FASN—melanoma	7.41e-06	6.25e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC5A5—melanoma	7.29e-06	6.14e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1A—melanoma	7.27e-06	6.13e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—melanoma	7.25e-06	6.11e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—melanoma	7.24e-06	6.1e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNAQ—melanoma	7.04e-06	5.93e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CD44—melanoma	7.04e-06	5.93e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CB—melanoma	7.03e-06	5.92e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1B1—melanoma	6.75e-06	5.69e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—melanoma	6.68e-06	5.63e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CG—melanoma	6.5e-06	5.48e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—melanoma	6.48e-06	5.47e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRAS—melanoma	6.47e-06	5.45e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—melanoma	6.41e-06	5.41e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARG—melanoma	6.27e-06	5.29e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK3—melanoma	6.19e-06	5.22e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—melanoma	6.07e-06	5.12e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—melanoma	6.03e-06	5.08e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—melanoma	5.94e-06	5.01e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK1—melanoma	5.89e-06	4.97e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—melanoma	5.89e-06	4.97e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CD—melanoma	5.71e-06	4.82e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALB—melanoma	5.64e-06	4.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—melanoma	5.57e-06	4.69e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCB1—melanoma	5.56e-06	4.68e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—melanoma	5.24e-06	4.42e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—melanoma	5.11e-06	4.31e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PRKCA—melanoma	5.11e-06	4.31e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ERCC2—melanoma	5.07e-06	4.28e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CB—melanoma	4.98e-06	4.2e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—melanoma	4.94e-06	4.16e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—melanoma	4.73e-06	3.99e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—melanoma	4.53e-06	3.82e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—melanoma	4.3e-06	3.63e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—melanoma	4.28e-06	3.61e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—melanoma	4.18e-06	3.52e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CG—melanoma	4e-06	3.38e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARG—melanoma	3.87e-06	3.26e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CD—melanoma	3.52e-06	2.97e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—melanoma	3.5e-06	2.95e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALB—melanoma	3.48e-06	2.93e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CB—melanoma	3.07e-06	2.59e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—melanoma	3.04e-06	2.56e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—melanoma	3.04e-06	2.56e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—melanoma	2.65e-06	2.24e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—melanoma	2.48e-06	2.09e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—melanoma	1.87e-06	1.58e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—melanoma	1.53e-06	1.29e-05	CbGpPWpGaD
